This study is in progress, not accepting new patients
A Study of AMG 757 in Participants With Neuroendocrine Prostate Cancer
Summary
- Eligibility
- for males ages 18 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startestimated completion
- Principal Investigator
- by Rahul Aggarwal
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Rahul Aggarwal
I am a Medical Oncologist within the Division of Hematology/Oncology at the University of California San Francisco. My clinical practice focuses on patients with advanced solid tumor malignancies with a particular emphasis on genitourinary malignancies including prostate, kidney, bladder, and testicular cancer. I serve as the Co-Leader for the GU Medical Oncology program at UCSF.
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Amgen
- Links
- AmgenTrials clinical trials website
- ID
- NCT04702737
- Phase
- Phase 1 Prostate Cancer Research Study
- Study Type
- Interventional
- Participants
- About 41 people participating
- Last Updated